An open-label, multicenter, efficacy, and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results
dc.authorid | Viprakasit, Vip/0000-0003-3162-1849 | |
dc.authorid | CAPPELLINI, MARIA DOMENICA/0000-0001-8676-6864 | |
dc.authorscopusid | 7401512064 | |
dc.authorscopusid | 35433934600 | |
dc.authorscopusid | 6701871501 | |
dc.authorscopusid | 7403427269 | |
dc.authorscopusid | 6602510535 | |
dc.authorscopusid | 7003851192 | |
dc.authorscopusid | 6603634753 | |
dc.authorwosid | CAPPELLINI, MARIA DOMENICA/B-4475-2017 | |
dc.contributor.author | Lai, Yong-Rong | |
dc.contributor.author | Cappellini, Maria Domenica | |
dc.contributor.author | Aydinok, Yesim | |
dc.contributor.author | Porter, John | |
dc.contributor.author | Karakas, Zeynep | |
dc.contributor.author | Viprakasit, Vip | |
dc.contributor.author | Siritanaratkul, Noppadol | |
dc.date.accessioned | 2023-01-12T19:49:38Z | |
dc.date.available | 2023-01-12T19:49:38Z | |
dc.date.issued | 2022 | |
dc.department | N/A/Department | en_US |
dc.description.abstract | [No Abstract Available] | en_US |
dc.description.sponsorship | Novartis Pharmaceuticals Corporation | en_US |
dc.description.sponsorship | This study was sponsored and funded by Novartis Pharmaceuticals Corporation. | en_US |
dc.identifier.doi | 10.1002/ajh.26592 | |
dc.identifier.endpage | E284 | en_US |
dc.identifier.issn | 0361-8609 | |
dc.identifier.issn | 1096-8652 | |
dc.identifier.issue | 8 | en_US |
dc.identifier.pmid | 35560253 | en_US |
dc.identifier.scopus | 2-s2.0-85130696116 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | E281 | en_US |
dc.identifier.uri | https://doi.org/10.1002/ajh.26592 | |
dc.identifier.uri | https://hdl.handle.net/11454/75864 | |
dc.identifier.volume | 97 | en_US |
dc.identifier.wos | WOS:000800529100001 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.relation.ispartof | American Journal of Hematology | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | An open-label, multicenter, efficacy, and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results | en_US |
dc.type | Letter | en_US |